Targeting endogenous and therapy-induced dependence on BCL-XL in high grade serous ovarian carcinoma

被引：0
|
作者：
Johnson, Lissah
Qin, Xingping
Fraser, Cameron
Stover, Elizabeth
Yang, Yang
Zhou, Daohong
Rueda, Bo
Sarosiek, Kristopher
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6161
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Serous Endometrial Intraepithelial Carcinoma with High-Grade Serous Ovarian Carcinoma: A Synchronous Presentation
    Ramya Yethadka
    Ranjitha Vodigenahalli Nagaraj
    Indian Journal of Gynecologic Oncology, 2024, 22
  • [32] Serous Endometrial Intraepithelial Carcinoma with High-Grade Serous Ovarian Carcinoma: A Synchronous Presentation
    Yethadka, Ramya
    Nagaraj, Ranjitha Vodigenahalli
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (01)
  • [33] Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis
    Li, Hong-Xia
    Lu, Zhao-Hui
    Shen, Keng
    Cheng, Wen-Jun
    Malpica, Anais
    Zhang, Jing
    Wei, Jian-Jun
    Zhang, Zhi-Hong
    Liu, Jinsong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (03): : 848 - 857
  • [34] Patterns of tumor evolution in high grade serous ovarian carcinoma
    Verhaak, Roel G. W.
    Chang, Kyle
    Kim, Hoon
    Carter, Scott L.
    Schultz, Nikolaus
    Zhao, Fengmei
    Shen, Hui
    Laird, Peter
    Sinah, Rileen
    Muzny, Donna
    Reid, Jeff
    Nu, Jiangong
    Drummond, Jennifer
    Getz, Gad
    Levine, Douglas A.
    Wheeler, David A.
    CANCER RESEARCH, 2012, 72
  • [35] Personalising Treatment for High-Grade Serous Ovarian Carcinoma
    Cojocaru, E.
    Parkinson, C. A.
    Brenton, J. D.
    CLINICAL ONCOLOGY, 2018, 30 (08) : 515 - 524
  • [36] Molecular Management of High-Grade Serous Ovarian Carcinoma
    Punzon-Jimenez, Paula
    Lago, Victor
    Domingo, Santiago
    Simon, Carlos
    Mas, Aymara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [37] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
  • [38] Combined MEK and BCL-2/XL inhibition as a potential drug combination for the treatment of high-grade serous ovarian cancer
    Iavarone, Claudia
    Zervantonakis, Ioannis
    Selfors, Laura M.
    Palakurthi, Sangeetha
    Liu, Joyce F.
    Matulonis, Ursula A.
    Drapkin, Ronny I.
    Mills, Gordon B.
    Leverson, Joel D.
    Sampath, Deepak
    Brugge, Joan S.
    CANCER RESEARCH, 2017, 77
  • [39] Targeting RAS and downstream signaling in high-grade serous ovarian carcinoma with novel RAS inhibitors
    Mattox, Tyler E.
    Norton, Tiffany S.
    Keeton, Adam B.
    Ward, Antonio B.
    Maxuitenko, Yulia Y.
    Berry, Kristy L.
    Zhu, Bing
    Musiyenko, Alla
    Gavin, Elaine
    Ramirez-Alcantara, Veronica
    Chen, Xi
    Valiyaveettil, Jacob
    Scalici, Jennifer
    Rocconi, Rodney P.
    Piazza, Gary A.
    da Silva, Luciana Madeira
    CANCER RESEARCH, 2019, 79 (13)
  • [40] Decreased Expression of Beclin 1 Correlates Closely with Bcl-xL Expression and Poor Prognosis of Ovarian Carcinoma
    Lin, Huan-Xin
    Qiu, Hui-Juan
    Zeng, Fei
    Rao, Hui-Lan
    Yang, Guo-Fen
    Kung, Hsiang-Fu
    Zhu, Xiao-Feng
    Zeng, Yi-Xin
    Cai, Mu-Yan
    Xie, Dan
    PLOS ONE, 2013, 8 (04):
12345